GENETIQ Trademark

Trademark Overview


On Tuesday, February 20, 2024, a trademark application was filed for GENETIQ with the United States Patent and Trademark Office. The USPTO has given the GENETIQ trademark a serial number of 98413156. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 11, 2024. This trademark is owned by PREPAIRE IRELAND IP HOLDING LIMITED. The GENETIQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Supplements used in genetic therapy and immunotherapy therapy; Nutraceuticals used as supplements; herbal preparations used as supplements; pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy

Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy; laboratories, clinics, hospitals providing immunotherapy therapy and genetic therapy; laboratories, clinics, and hospitals using substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells
genetiq

General Information


Serial Number98413156
Word MarkGENETIQ
Filing DateTuesday, February 20, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSupplements used in genetic therapy and immunotherapy therapy; Nutraceuticals used as supplements; herbal preparations used as supplements; pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy
Goods and ServicesProduct development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy; laboratories, clinics, hospitals providing immunotherapy therapy and genetic therapy; laboratories, clinics, and hospitals using substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePREPAIRE IRELAND IP HOLDING LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D18T3Y1
IE

Trademark Events


Event DateEvent Description
Thursday, March 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2024ASSIGNED TO EXAMINER
Wednesday, September 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NON-FINAL ACTION E-MAILED
Friday, February 23, 2024NEW APPLICATION ENTERED